BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abushouk AI, El-Husseny MWA, Magdy M, Ismail A, Attia A, Ahmed H, Pallanti R, Negida A. Evidence for association between hepatitis C virus and Parkinson's disease. Neurol Sci 2017;38:1913-20. [PMID: 28780707 DOI: 10.1007/s10072-017-3077-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Philippens IH. Refinement of the MPTP model for Parkinson’s disease in the marmoset. Drug Discovery Today: Disease Models 2017;25-26:53-61. [DOI: 10.1016/j.ddmod.2018.10.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Linard M, Ravier A, Mougué L, Grgurina I, Boutillier AL, Foubert-Samier A, Blanc F, Helmer C. Infectious Agents as Potential Drivers of α-Synucleinopathies. Mov Disord 2022. [PMID: 35040520 DOI: 10.1002/mds.28925] [Reference Citation Analysis]
3 Ahmed H, Abushouk AI, Attia A, Gadelkarim M, Gabr M, Negida A, Abdel-daim MM. Safety and efficacy of sofosbuvir plus velpatasvir with or without ribavirin for chronic hepatitis C virus infection: A systematic review and meta-analysis. Journal of Infection and Public Health 2018;11:156-64. [DOI: 10.1016/j.jiph.2017.09.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
4 Melnick M, Gonzales P, LaRocca TJ, Song Y, Wuu J, Benatar M, Oskarsson B, Petrucelli L, Dowell RD, Link CD, Prudencio M. Application of a bioinformatic pipeline to RNA-seq data identifies novel viruslike sequence in human blood. G3 (Bethesda) 2021:jkab141. [PMID: 33914880 DOI: 10.1093/g3journal/jkab141] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Choi HY, Mai TH, Kim KA, Cho H, Ki M. Association between viral hepatitis infection and Parkinson's disease: A population-based prospective study. J Viral Hepat 2020;27:1171-8. [PMID: 32558154 DOI: 10.1111/jvh.13346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Su TH, Yang HC, Tseng TC, Chou SW, Lin CH, Liu CH, Liu CJ, Chen CL, Kao JH. Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism. Mov Disord 2019;34:1882-90. [PMID: 31505068 DOI: 10.1002/mds.27848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lin WY, Lin MS, Weng YH, Yeh TH, Lin YS, Fong PY, Wu YR, Lu CS, Chen RS, Huang YZ. Association of Antiviral Therapy With Risk of Parkinson Disease in Patients With Chronic Hepatitis C Virus Infection. JAMA Neurol 2019;76:1019-27. [PMID: 31168563 DOI: 10.1001/jamaneurol.2019.1368] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
8 Lotz SK, Blackhurst BM, Reagin KL, Funk KE. Microbial Infections Are a Risk Factor for Neurodegenerative Diseases. Front Cell Neurosci 2021;15:691136. [PMID: 34305533 DOI: 10.3389/fncel.2021.691136] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Abbas MM, Xu Z, Tan LCS. Epidemiology of Parkinson's Disease-East Versus West. Mov Disord Clin Pract 2018;5:14-28. [PMID: 30363342 DOI: 10.1002/mdc3.12568] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 11.0] [Reference Citation Analysis]